These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 34981814)
1. Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review). Lu J; Ding J; Liu Z; Chen T Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 34981814 [TBL] [Abstract][Full Text] [Related]
2. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies. Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803 [TBL] [Abstract][Full Text] [Related]
3. The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy. Dass SA; Selva Rajan R; Tye GJ; Balakrishnan V Hum Vaccin Immunother; 2021 Sep; 17(9):2981-2994. PubMed ID: 33989511 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic applications of monoclonal antibodies. Berger M; Shankar V; Vafai A Am J Med Sci; 2002 Jul; 324(1):14-30. PubMed ID: 12120821 [TBL] [Abstract][Full Text] [Related]
5. Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications. Bazan J; Całkosiński I; Gamian A Hum Vaccin Immunother; 2012 Dec; 8(12):1817-28. PubMed ID: 22906939 [TBL] [Abstract][Full Text] [Related]
6. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients]. Kubo O; Takakura K Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965 [TBL] [Abstract][Full Text] [Related]
7. Development of therapeutic antibodies for the treatment of diseases. Wang Z; Wang G; Lu H; Li H; Tang M; Tong A Mol Biomed; 2022 Nov; 3(1):35. PubMed ID: 36418786 [TBL] [Abstract][Full Text] [Related]
8. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies. Vollmers HP; Brändlein S Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal and recombinant antibodies, 30 years after .. Laffly E; Sodoyer R Hum Antibodies; 2005; 14(1-2):33-55. PubMed ID: 16424599 [TBL] [Abstract][Full Text] [Related]
10. Affinity maturation and functional dissection of a humanised anti-RAGE monoclonal antibody by ribosome display. Hufton SE Methods Mol Biol; 2012; 805():403-22. PubMed ID: 22094819 [TBL] [Abstract][Full Text] [Related]
11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
12. [Antibody treatment for cancer]. Sasaki S; Ozeki I; Takekawa M; Tsujisaki M; Imai K Nihon Geka Gakkai Zasshi; 2000 Sep; 101(9):607-11. PubMed ID: 11022675 [TBL] [Abstract][Full Text] [Related]
13. Phage display antibody libraries: A robust approach for generation of recombinant human monoclonal antibodies. Kumar R; Parray HA; Shrivastava T; Sinha S; Luthra K Int J Biol Macromol; 2019 Aug; 135():907-918. PubMed ID: 31170490 [TBL] [Abstract][Full Text] [Related]
14. [Advances of monoclonal antibodies and analysis of marketed antibody drugs]. Gu G; Fang M Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1431-1447. PubMed ID: 38783807 [TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibodies from transgenic mice. Lonberg N Handb Exp Pharmacol; 2008; 181(181):69-97. PubMed ID: 18071942 [TBL] [Abstract][Full Text] [Related]
17. Hybridoma technology: the preferred method for monoclonal antibody generation for Zaroff S; Tan G Biotechniques; 2019 Sep; 67(3):90-92. PubMed ID: 31347924 [No Abstract] [Full Text] [Related]
18. Phage display-derived human antibodies in clinical development and therapy. Frenzel A; Schirrmann T; Hust M MAbs; 2016 Oct; 8(7):1177-1194. PubMed ID: 27416017 [TBL] [Abstract][Full Text] [Related]
19. Advances in the Isolation of Specific Monoclonal Rabbit Antibodies. Zhang Z; Liu H; Guan Q; Wang L; Yuan H Front Immunol; 2017; 8():494. PubMed ID: 28529510 [TBL] [Abstract][Full Text] [Related]
20. Historical development of monoclonal antibody therapeutics. Nissim A; Chernajovsky Y Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]